Ozempic – What’s the truth behind the hype? | DW Documentary

GHealth News – This documentary examines the controversial marketing strategies surrounding a weight-loss injection hailed as a groundbreaking scientific innovation. The injection’s active ingredient, Semaglutide, was originally developed for the treatment of diabetes. For individuals who are slightly or moderately overweight, it appears to offer a convenient method for weight reduction. However, experts caution against its use without proper medical supervision.

“For those looking to lose just a few kilograms, these new drugs pose significant risks. We still lack long-term data,” warns Dr. Lucie Favre from an obesity consultation center in Lausanne, Switzerland. She emphasizes that for many individuals, the core issue lies in unhealthy eating habits and inadequate physical activity. “Relying solely on the injection addresses the symptoms rather than the root cause,” Dr. Favre adds.

This film explores both the potential benefits and the associated risks of this emerging medication.